Find Resources

The U.S. Department of Health and Human Services has announced the establishment of the Office of Long COVID Research and Practice to address the long-term effects of COVID-19. This office will coordinate the government’s response to Long COVID, including associated conditions and the implementation of a National Research Action Plan. Over 14 federal departments and divisions are working together to reduce the impact of Long COVID and improve the quality of life for those affected. Additionally, the National Institutes of Health has launched the RECOVER Initiative, a $1.15 billion research program focused on understanding, treating, and preventing Long COVID. The initiative involves large-scale studies and clinical trials to develop interventions for the condition.

The article discusses the challenges and frustrations surrounding Long COVID research in the United States. Despite substantial investments and numerous research efforts, progress in understanding and treating Long COVID has been slow and disappointing. Experts and patient advocates have criticized the research community for its focus on disease development rather than direct patient care, duplication of studies, and a lack of clinical trials. The authors propose a new hypothesis that Long COVID may be a form of post-infectious syndrome or chronic fatigue syndrome, suggesting that traditional biomedical research approaches may not yield meaningful results. Instead, they advocate for a shift towards health services research and measures that directly impact patients’ welfare, including prevention, improved prognosis, access to empathetic care, and quality of life issues. They emphasize the need for collaboration between researchers, patients, and advocacy groups to reset the research agenda effectively.

The article highlights the lessons learned from the COVID-19 pandemic and their influence on preparations for future public health emergencies. While the federal Public Health Emergency for COVID-19 is set to end in May 2023, the FDA emphasizes the continued importance of COVID-19 vaccines and treatments. Addressing misinformation and strengthening supply chain resilience are key priorities, and the FDA is developing more efficient inspection planning systems. Modernizing FDA authorities and maintaining a commitment to planning for the future are also emphasized to enhance national security and public health preparedness.

Using a grant from the National Science Foundation, Predictive Intelligence for Pandemic Prevention (PIPP) developed tools and systems to respond effectively to infectious disease pandemics. Recommendations from this work include avoiding reinvention of the wheel by centralizing and standardizing approaches to pandemic response planning, collaboration and information sharing among public health stakeholders, investing in high-performance computing and data management systems for public health, creating a national center for pandemic response, developing playbooks for fast-moving threats, and identifying sustainable and scalable solutions.

This study assessed the impacts of the pandemic on health-related and economic factors of rural well-being in Western states. Findings suggest severe impacts on employment, life satisfaction, mental health, and economic outlook across all ages, ethnicity, education levels, and sex. The authors encourage readers to use these findings as a catalyst to larger interdiscplinary COVID-19 research that integrates rural considerations in decision-making.

This qualitative study conducted in urban areas of northern and southern China examined how digital detection surveillance for infectious diseases was perceived and experienced by primary care physicians and patients; the findings discuss important ethical considerations for ensuring patient autonomy and rights when digital detection surveillance is used.

This article emphasizes the importance of funding primary care, providing direct evidence on the benefits of utilizing primary care-oriented systems to achieve better health outcomes.

Director of the Health Equity Core at Harvard Medical School, Professor Sprague Martinez has organized a team of partners to identify the impact of long COVID on Black and Latinx communities in Massachusetts and barriers they experience in accessing treatment. The project is part of the Massachusetts Consortium on Pathogen Readiness, which aims to address the challenges of COVID-19 and future pandemics. The Health Equity Core focuses on understanding the impact of long COVID on diverse communities, increasing access to treatment and resources, and influencing relevant policies. The team includes partners from various institutions and will emphasize community engagement, data collection, dissemination, and policy advocacy efforts.

This article discusses the Foundation for Opioid Response Efforts (FORE) distribution of $1.3 million in grants to organizations studying the potential permanent adoption of COVID-19 care access measures to promote health equity in opioid use disorder treatment. The grants aim to investigate the impact of temporary policies, such as virtual care, on access to care and patient outcomes. The studies will explore how relaxed prescribing policies for buprenorphine, telehealth strategies, and other COVID-19 measures have affected patient access and outcomes, particularly among underserved populations. The research will inform evidence-based policies to sustain access to better care beyond the pandemic and address the ongoing opioid crisis.

This article highlights the successful implementation of a pediatric pharmacy team’s strategic plan during the COVID-19 pandemic. The plan, titled “Vision 2020,” aimed to enhance team cohesion, accountability, and service quality. Despite pandemic challenges, the team achieved numerous goals and objectives through effective data gathering, buy-in from management, and progress tracking. The article emphasizes the importance of team-level strategic planning for clinical service lines.